New Key Statistics Module, Z-Score and F-Score
OTCPK:DIUXF Key Ratios
| Market Cap $ M | 166.22 |
| Enterprise Value $ M | 156.04 |
| P/E(ttm) | 720.00 |
| PE Ratio without NRI | 720.00 |
| Forward PE Ratio | 250.00 |
| Price/Book | 3.01 |
| Price/Sales | 3.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 51.00 |
| EPS (TTM) $ | 0.001 |
| Beneish M-Score | -2.23 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 67.70 |
| y-y EBITDA Growth Rate % | 121.20 |
| EV-to-EBIT | 321.32 |
| EV-to-EBITDA | 18.74 |
| PEG | 10.64 |
| Shares Outstanding M | 84.63 |
| Net Margin (%) | 0.25 |
| Operating Margin % | 0.11 |
| Pre-tax Margin (%) | 0.79 |
| Quick Ratio | 3.43 |
| Current Ratio | 3.43 |
| ROA % (ttm) | 0.20 |
| ROE % (ttm) | 0.25 |
| ROIC % (ttm) | 0.04 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.13 |
DIUXF Number of Guru Trades
DIUXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:DIUXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:DIUXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Diaceutics PLC Insider Transactions
No Available Data
News about OTCPK:DIUXF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers